Latest News on PRVA

Financial News Based On Company


Advertisement
Advertisement

Privia Health ( PRVA ) Misses Q2 Earnings Estimates

https://www.zacks.com/stock/news/2677849/privia-health-prva-misses-q2-earnings-estimates
Privia Health (PRVA) delivered earnings and revenue surprises of -60.00% and +11.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Privia Health Reports Second Quarter 2025 Financial Results

https://www.globenewswire.com/news-release/2025/08/07/3128986/0/en/Privia-Health-Reports-Second-Quarter-2025-Financial-Results.html
Strong Performance Across Key Metrics. Guidance Raised to Above High End of Range for Practice Collections, GAAP Revenue, Platform Contribution, Adj ...

Privia Health to Report Second Quarter 2025 Results on Thursday, August 7

https://www.globenewswire.com/news-release/2025/07/10/3113334/0/en/Privia-Health-to-Report-Second-Quarter-2025-Results-on-Thursday-August-7.html
ARLINGTON, Va., July 10, 2025 ( GLOBE NEWSWIRE ) -- Privia Health Group, Inc. ( Nasdaq: PRVA ) today announced that it expects to release financial results for its second-quarter and six-month periods ended June 30, 2025 before market open on Thursday, August 7, 2025.

Privia Health Announces Appointment of Lance V. Berberian to its Board of Directors

https://www.globenewswire.com/news-release/2025/07/08/3111799/0/en/Privia-Health-Announces-Appointment-of-Lance-V-Berberian-to-its-Board-of-Directors.html
Berberian brings significant technology leadership and cybersecurity expertise Berberian brings significant technology leadership and cybersecurity expertise ...

Privia Health ( PRVA ) Misses Q1 Earnings Estimates

https://www.zacks.com/stock/news/2464871/privia-health-prva-misses-q1-earnings-estimates
Privia Health (PRVA) delivered earnings and revenue surprises of -50% and 5.37%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Advertisement

Privia Health Reports First Quarter 2025 Financial Results

https://www.globenewswire.com/news-release/2025/05/08/3076965/0/en/Privia-Health-Reports-First-Quarter-2025-Financial-Results.html
Privia Health Reports Strong First Quarter Performance and Operating Execution. Enters the State of Arizona. FY'25 Outlook Raised ...

Countdown to Privia Health ( PRVA ) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS

https://www.zacks.com/stock/news/2463902/countdown-to-privia-health-prva-q1-earnings-a-look-at-estimates-beyond-revenue-and-eps
Get a deeper insight into the potential performance of Privia Health (PRVA) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Investigating Privia Health Gr's Standing In Health Care Providers & Services Industry Compared To Competitors - Privia Health Gr ( NASDAQ:PRVA )

https://www.benzinga.com/insights/news/25/04/44842129/investigating-privia-health-grs-standing-in-health-care-providers-amp-services-industry-compared-to
In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry enthusiasts. In this article, we will perform an extensive industry comparison, evaluating Privia Health Gr PRVA in relation to its major competitors in ...

Medicare Advantage Rates Expected To Climb Over 5%: CMS - Alignment Healthcare ( NASDAQ:ALHC )

https://www.benzinga.com/government/regulations/25/04/44694563/medicare-advantage-rates-expected-to-climb-over-5-in-2026-easing-pressure-on-managed-care
2026 Medicare Advantage payments to rise by 5.06%, up from the prior 2.23% estimate. CMS revised the effective growth rate to 9.04%, from an earlier 5.93%. Feel unsure about the market's next move? Copy trade alerts from Matt Maley-a Wall Street veteran who consistently finds profits in volatile ...

How Is The Market Feeling About Privia Health Gr? - Privia Health Gr ( NASDAQ:PRVA )

https://www.benzinga.com/insights/short-sellers/25/04/44670746/how-is-the-market-feeling-about-privia-health-gr
Privia Health Gr's PRVA short percent of float has risen 6.73% since its last report. The company recently reported that it has 4.43 million shares sold short, which is 5.87% of all regular shares that are available for trading.
Advertisement

Parexel Announces Updates to Board of Directors - Goldman Sachs Group ( NYSE:GS )

https://www.benzinga.com/pressreleases/25/03/g44140828/parexel-announces-updates-to-board-of-directors
Jeff Bernstein, Partner, Private Equity, Goldman Sachs Asset Management, and Co-Head, Goldman Sachs Healthcare Private Equity Investing, joins as new Director. Mr. Bernstein succeeds Michael Bruun in the Goldman Sachs Board seat as part of a planned rotation.

Privia Health ( PRVA ) Lags Q4 Earnings Estimates

https://www.zacks.com/stock/news/2422531/privia-health-prva-lags-q4-earnings-estimates
Privia Health (PRVA) delivered earnings and revenue surprises of -50% and 10.37%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results

https://www.globenewswire.com/news-release/2025/02/27/3033627/0/en/Privia-Health-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html
• All 2024 Operating and Financial Metrics Above High End of Guidance Ranges • Very strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023 • Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital ...

Seeking Clues to Privia Health ( PRVA ) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics

https://www.zacks.com/stock/news/2421071/seeking-clues-to-privia-health-prva-q4-earnings-a-peek-into-wall-street-projections-for-key-metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Privia Health (PRVA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.

IRhythm Technologies ( IRTC ) Beats Q4 Earnings and Revenue Estimates

https://www.zacks.com/stock/news/2419056/irhythm-technologies-irtc-beats-q4-earnings-and-revenue-estimates
iRhythm Technologies (IRTC) delivered earnings and revenue surprises of 103.33% and 4.19%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Advertisement

Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27

https://www.globenewswire.com/news-release/2025/01/24/3014901/0/en/Privia-Health-to-Report-Fourth-Quarter-2024-Results-on-Thursday-February-27.html
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February ...

Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27 - Privia Health Gr ( NASDAQ:PRVA )

https://www.benzinga.com/pressreleases/25/01/g43190161/privia-health-to-report-fourth-quarter-2024-results-on-thursday-february-27
ARLINGTON, Va., Jan. 24, 2025 ( GLOBE NEWSWIRE ) -- Privia Health Group, Inc. PRVA today announced that it expects to release financial results for its fourth quarter and full-year periods ended December 31, 2024 before market open on Thursday, February 27, 2025.

DH or PRVA: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2397633/dh-or-prva-which-is-the-better-value-stock-right-now
DH vs. PRVA: Which Stock Is the Better Value Option?

DH vs. PRVA: Which Stock Is the Better Value Option?

https://www.zacks.com/stock/news/2386466/dh-vs-prva-which-stock-is-the-better-value-option
Investors with an interest in Medical Info Systems stocks have likely encountered both Definitive Healthcare Corp. ( DH Quick QuoteDH - ) and Privia Health ( PRVA Quick QuotePRVA - ) . But which of these two stocks presents investors with the better value opportunity right now?

DH vs. PRVA: Which Stock Should Value Investors Buy Now?

https://www.zacks.com/stock/news/2379063/dh-vs-prva-which-stock-should-value-investors-buy-now
DH vs. PRVA: Which Stock Is the Better Value Option?
Advertisement

DH or PRVA: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2371702/dh-or-prva-which-is-the-better-value-stock-right-now
DH vs. PRVA: Which Stock Is the Better Value Option?

Privia Health ( PRVA ) Misses Q3 Earnings Estimates

https://www.zacks.com/stock/news/2365960/privia-health-prva-misses-q3-earnings-estimates
Privia Health (PRVA) delivered earnings and revenue surprises of -50% and 5.67%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Clover Health Investments, Corp. ( CLOV ) Reports Q3 Loss, Lags Revenue Estimates

https://www.zacks.com/stock/news/2365711/clover-health-investments-corp-clov-reports-q3-loss-lags-revenue-estimates
Clover Health Investments (CLOV) delivered earnings and revenue surprises of 33.33% and 4.78%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Sonendo, Inc. ( SONX ) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

https://www.zacks.com/stock/news/2364453/sonendo-inc-sonx-may-report-negative-earnings-know-the-trend-ahead-of-next-weeks-release
Sonendo (SONX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cencora to Report Q4 Earnings: What's in Store for the Stock?

https://www.zacks.com/stock/news/2363707/cencora-to-report-q4-earnings-whats-in-store-for-the-stock
COR's fiscal fourth-quarter results are likely to reflect decent U.S. Healthcare Solutions segmental performance.
Advertisement

Revvity to Report Q3 Earnings: What's in Store for the Stock?

https://www.zacks.com/stock/news/2362850/revvity-to-report-q3-earnings-whats-in-store-for-the-stock
RVTY third-quarter results are likely to reflect decent performance in the Diagnostics segment, while the Life Sciences segment is likely to face continued challenges in China.

Revvity to Report Q3 Earnings: What's in Store for the Stock?

https://www.zacks.com/stock/news/2362850/revvity-to-report-q3-earnings-whats-in-store-for-the-stock
RVTY third-quarter results are likely to reflect decent performance in the Diagnostics segment, while the Life Sciences segment is likely to face continued challenges in China.

Privia Health ( PRVA ) Earnings Expected to Grow: Should You Buy?

https://www.zacks.com/stock/news/2361930/privia-health-prva-earnings-expected-to-grow-should-you-buy
Privia Health (PRVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program

https://www.globenewswire.com/news-release/2024/10/29/2971287/0/en/Privia-Health-Reports-2023-Performance-Results-in-the-Medicare-Shared-Savings-Program.html
ARLINGTON, Va., Oct. 29, 2024 ( GLOBE NEWSWIRE ) -- Privia Health Group, Inc. ( Nasdaq: PRVA ) today announced that its Accountable Care Organizations ( ACOs ) achieved shared savings of $176.6 million through the Medicare Shared Savings Program ( MSSP ) for the 2023 performance year, a 34.1% ...

Lower Instruments Sales to Hurt TXG Q3 Earnings, Prelim Sales Down

https://www.zacks.com/stock/news/2358968/lower-instruments-sales-to-hurt-txg-q3-earnings-prelim-sales-down
Per a preliminary report from 10x Genomics, the company's revenues will decline for the third quarter. Lower Instruments sales are likely to have been partially offset by consumable sales growth.
Advertisement

Privia Health Lags Q2 Earnings Estimates - CareCloud ( NASDAQ:CCLD ) , Privia Health Gr ( NASDAQ:PRVA )

https://www.benzinga.com/news/earnings/24/08/40251343/privia-health-lags-q2-earnings-estimates
Privia Health PRVA came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of ...

Privia Health ( PRVA ) Lags Q2 Earnings Estimates

https://www.zacks.com/stock/news/2318811/privia-health-prva-lags-q2-earnings-estimates
Privia Health (PRVA) delivered earnings and revenue surprises of -40% and 2.40%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Privia Health Reports Second Quarter 2024 Financial Results

https://www.globenewswire.com/news-release/2024/08/08/2926681/0/en/Privia-Health-Reports-Second-Quarter-2024-Financial-Results.html
ARLINGTON, Va., Aug. 08, 2024 ( GLOBE NEWSWIRE ) -- Privia Health Group, Inc. ( Nasdaq: PRVA ) today announced financial results for the second quarter and six months ended June 30, 2024.

Health Catalyst ( HCAT ) Tops Q2 Earnings and Revenue Estimates

https://www.zacks.com/stock/news/2318579/health-catalyst-hcat-tops-q2-earnings-and-revenue-estimates
Health Catalyst (HCAT) delivered earnings and revenue surprises of 33.33% and 1.21%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Axonics Modulation Technologies ( AXNX ) Surpasses Q2 Earnings and Revenue Estimates

https://www.zacks.com/stock/news/2314642/axonics-modulation-technologies-axnx-surpasses-q2-earnings-and-revenue-estimates
Axonics (AXNX) delivered earnings and revenue surprises of 62.50% and 1.71%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Advertisement

Earnings Preview: Privia Health ( PRVA ) Q2 Earnings Expected to Decline

https://www.zacks.com/stock/news/2314284/earnings-preview-privia-health-prva-q2-earnings-expected-to-decline
Privia Health (PRVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Privia Health to Participate in the William Blair Growth Stock Conference - Privia Health Gr ( NASDAQ:PRVA )

https://www.benzinga.com/pressreleases/24/05/g39087026/privia-health-to-participate-in-the-william-blair-growth-stock-conference
ARLINGTON, Va., May 30, 2024 ( GLOBE NEWSWIRE ) -- Privia Health Group, Inc. PRVA today announced that its management team plans to present at the 44th Annual William Blair Growth Stock Conference on Wednesday, June 5, 2024, beginning at 11:00 am ET / 10:00 am CT.

Privia Health to Participate in the William Blair Growth Stock Conference

https://www.globenewswire.com/news-release/2024/05/30/2890859/0/en/Privia-Health-to-Participate-in-the-William-Blair-Growth-Stock-Conference.html
ARLINGTON, Va., May 30, 2024 ( GLOBE NEWSWIRE ) -- Privia Health Group, Inc. ( Nasdaq: PRVA ) today announced that its management team plans to present at the 44th Annual William Blair Growth Stock Conference on Wednesday, June 5, 2024, beginning at 11:00 am ET / 10:00 am CT.

Insiders Buying Hilton Worldwide And 2 Other Stocks - Hilton Worldwide Holdings ( NYSE:HLT )

https://www.benzinga.com/trading-ideas/long-ideas/24/05/39082633/insiders-buying-hilton-worldwide-and-2-other-stocks
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock.

DH or PRVA: Which Is the Better Value Stock Right Now?

https://www.zacks.com/stock/news/2272987/dh-or-prva-which-is-the-better-value-stock-right-now
DH vs. PRVA: Which Stock Is the Better Value Option?
Advertisement

Privia Health ( PRVA ) Misses Q1 Earnings and Revenue Estimates

https://www.zacks.com/stock/news/2271146/privia-health-prva-misses-q1-earnings-and-revenue-estimates
Privia Health (PRVA) delivered earnings and revenue surprises of -60% and 4.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Privia Health Reports First Quarter 2024 Financial Results

https://www.globenewswire.com/news-release/2024/05/09/2878519/0/en/Privia-Health-Reports-First-Quarter-2024-Financial-Results.html
ARLINGTON, Va., May 09, 2024 ( GLOBE NEWSWIRE ) -- Privia Health Group, Inc. ( Nasdaq: PRVA ) today announced financial results for the first quarter ended March 31, 2024. • Practice Collections of $707.7M, +7.4% versus 1Q'23, which includes a year-over-year reduction due to a shift of ...

Privia Health ( PRVA ) Misses Q4 Earnings Estimates

https://www.zacks.com/stock/news/2232192/privia-health-prva-misses-q4-earnings-estimates
Privia Health (PRVA) delivered earnings and revenue surprises of -60% and 3.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results

https://www.globenewswire.com/news-release/2024/02/27/2835782/0/en/Privia-Health-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
• Achieved All 2023 Operating and Financial Guidance Metrics • Proactive Steps to Limit Downside Risk Arrangements in Current Medicare Advantage Environment for More Favorable Contract Structures and Margin Contribution

Global Corporate Wellness Market Size is Estimated to Reach USD 94,649.56 million by 2031, Growing at a CAGR of 6.10%: Straits Research

https://www.benzinga.com/pressreleases/24/01/g36868545/global-corporate-wellness-market-size-is-estimated-to-reach-usd-94-649-56-million-by-2031-growing-
New York, United States, Jan. 31, 2024 ( GLOBE NEWSWIRE ) -- The policies, initiatives, and perks that make up corporate wellness programs target various risk factors and illnesses that affect employees and the firm.
Advertisement

Privia Health Appoints Edward C. Fargis as General Counsel

https://www.globenewswire.com/news-release/2024/01/29/2818906/0/en/Privia-Health-Appoints-Edward-C-Fargis-as-General-Counsel.html
ARLINGTON, Va., Jan. 29, 2024 ( GLOBE NEWSWIRE ) -- Privia Health Group, Inc. ( Nasdaq: PRVA ) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today. Mr. Fargis will serve as the Company's chief legal officer, working ...

Privia Health to Report Fourth Quarter and Full-Year 2023 Results on Tuesday, February 27

https://www.globenewswire.com/news-release/2024/01/23/2814079/0/en/Privia-Health-to-Report-Fourth-Quarter-and-Full-Year-2023-Results-on-Tuesday-February-27.html
Privia Health to Report Fourth Quarter and Full-Year 2023 Results on Tuesday, February ...

Privia Health to Report Fourth Quarter and Full-Year 2023 Results on Tuesday, February 27

https://markets.businessinsider.com/news/stocks/privia-health-to-report-fourth-quarter-and-full-year-2023-results-on-tuesday-february-27-1032987735
Privia Health to Report Fourth Quarter and Full-Year 2023 Results on Tuesday, February ...

Privia Health to Participate in the J.P. Morgan Healthcare Conference

https://www.globenewswire.com/news-release/2023/12/12/2794769/0/en/Privia-Health-to-Participate-in-the-J-P-Morgan-Healthcare-Conference.html
Privia Health (Nasdaq: PRVA) will present at the J.P. Morgan HC Conference on Monday, January 8, 2024, beginning at 6:45 pm ET / 3:45 pm PT ...

OMCL vs. PRVA: Which Stock Should Value Investors Buy Now?

https://www.zacks.com/stock/news/2178251/omcl-vs-prva-which-stock-should-value-investors-buy-now
OMCL vs. PRVA: Which Stock Is the Better Value Option?
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion